Cargando…
Advances in immunotherapy for triple-negative breast cancer
BACKGROUND: Immunotherapy has recently emerged as a treatment strategy which stimulates the human immune system to kill tumor cells. Tumor immunotherapy is based on immune editing, which enhances the antigenicity of tumor cells and increases the tumoricidal effect of immune cells. It also suppresses...
Autores principales: | Liu, Yang, Hu, Yueting, Xue, Jinqi, Li, Jingying, Yi, Jiang, Bu, Jiawen, Zhang, Zhenyong, Qiu, Peng, Gu, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474743/ https://www.ncbi.nlm.nih.gov/pubmed/37660039 http://dx.doi.org/10.1186/s12943-023-01850-7 |
Ejemplares similares
-
Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023) -
Targeting ferroptosis, the achilles’ heel of breast cancer: A review
por: Liu, Yang, et al.
Publicado: (2022) -
Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022) -
Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021) -
Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer
por: Zhu, Xudong, et al.
Publicado: (2023)